Qualitative Platelet Disorders Treatment Market Size & Share, by Treatment (Platelet Transfusion, Hormonal Therapy, Anti-fibrinolytic Medications, Genetic Counselling); End-user (Hospital, Ambulatory Surgical Center, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3782
  • Published Date: Apr 03, 2023
  • Report Format: PDF, PPT

Companies Dominating the Qualitative Platelet Disorders Treatment Landscape

    • Pfizer, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck & Co., Inc.
    • Siemens Healthcare GmbH
    • Boehringer Ingelheim International GmbH
    • Johnson & Johnson Services, Inc.
    • Baxter International, Inc.
    • Novartis AG
    • Abbott Laboratories
    • Sanofi-aventis Groupe
    • AbbVie Inc.

Browse Key Market Insights with Data Illustration:


In The News

  • Sanofi-aventis Groupe acquired Provention Bio, Inc., to provide best-in-class medications, and to provide those at risk of developing Stage 3 type 1 diabetes with life-changing advantages. Further, the acquisition also advances the company's strategy to move towards pharmaceuticals with distinctive profiles.

  • acquired cardiovascular Systems, Inc. (CSI), to enhance its industry-leading vascular device solutions with new innovations.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3782
  • Published Date: Apr 03, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing changes in lifestyle and the geriatric population are the major factors driving the market growth.

The market is anticipated to attain a CAGR of ~9% over the forecast period, i.e., 2023-2035.

Exorbitant cost of treatment and the insufficient access to appropriate care in middle- and low-income countries are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Merck & Co., Inc., Siemens Healthcare GmbH, Boehringer Ingelheim International GmbH, Johnson & Johnson Services, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by treatment, end user, and by region.

The genetic counselling segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying